BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND KLK2, P20151, 3817, ENSG00000167751, MGC12201, hK2, KLK2A2 AND Prognosis
16 results:

  • 1. AMPK-HIF-1α signaling enhances glucose-derived de novo serine biosynthesis to promote glioblastoma growth.
    Yun HJ; Li M; Guo D; Jeon SM; Park SH; Lim JS; Lee SB; Liu R; Du L; Kim SH; Shin TH; Eyun SI; Park YY; Lu Z; Lee JH
    J Exp Clin Cancer Res; 2023 Dec; 42(1):340. PubMed ID: 38098117
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The survivin-ran inhibitor LLP-3 decreases oxidative phosphorylation, glycolysis and growth of neuroblastoma cells.
    Galiger C; Zohora FT; Dorneburg C; Tews D; Debatin KM; Beltinger C
    BMC Cancer; 2023 Nov; 23(1):1148. PubMed ID: 38007466
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. KIF22 promotes the proliferation and glycolysis of melanoma by activating EGFR/STAT3 signaling.
    Zhong Z; Zhong H
    Clinics (Sao Paulo); 2023; 78():100307. PubMed ID: 37944197
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Model for predicting prognosis and immunotherapy based on CD
    Bao W; Song Z; Wan H; Yu X; Chen Z; Jiang Y; Chen X; Le K
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):9839-9855. PubMed ID: 37248319
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. circPKD2 inhibits the glioma cell proliferation, invasion and glycolytic metabolism through regulating the miR-1278/LATS2 axis.
    Liu F; Wu H; Wu G; Long J; Dai J; Wang Z
    Neurosci Lett; 2023 Mar; 801():137126. PubMed ID: 36796622
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Homeobox A3 and KDM6A cooperate in transcriptional control of aerobic glycolysis and glioblastoma progression.
    Yang R; Zhang G; Dong Z; Wang S; Li Y; Lian F; Liu X; Li H; Wei X; Cui H
    Neuro Oncol; 2023 Apr; 25(4):635-647. PubMed ID: 36215227
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The mitotic regulator RCC2 promotes glucose metabolism through BACH1-dependent transcriptional upregulation of hexokinase II in glioma.
    Liu T; Wang Y; Wang Y; Cheung SK; Or PM; Wong CW; Guan J; Li Z; Yang W; Tu Y; Wang J; Ho WL; Gu H; Cheng AS; Tsui SK; Chan AM
    Cancer Lett; 2022 Nov; 549():215914. PubMed ID: 36116740
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The expression of Hexokinase 2 and its hub genes are correlated with the prognosis in glioma.
    Huang Y; Ouyang F; Yang F; Zhang N; Zhao W; Xu H; Yang X
    BMC Cancer; 2022 Aug; 22(1):900. PubMed ID: 35982398
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. RASD2 promotes the development and metastasis of uveal melanoma via enhancing glycolysis.
    Xie M; Xin C
    Biochem Biophys Res Commun; 2022 Jun; 610():92-98. PubMed ID: 35461072
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. F-box protein 17 promotes glioma progression by regulating glycolysis pathway.
    Deng C; Li H; Li Q
    Biosci Biotechnol Biochem; 2022 Mar; 86(4):455-463. PubMed ID: 35044455
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patients.
    Applebaum MA; Jha AR; Kao C; Hernandez KM; DeWane G; Salwen HR; Chlenski A; Dobratic M; Mariani CJ; Godley LA; Prabhakar N; White K; Stranger BE; Cohn SL
    Oncotarget; 2016 Nov; 7(47):76816-76826. PubMed ID: 27765905
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma.
    Liu YL; Lu MY; Chang HH; Lu CC; Lin DT; Jou ST; Yang YL; Lee YL; Huang SF; Jeng YM; Lee H; Miser JS; Lin KH; Liao YF; Hsu WM; Tzen KY
    Oncotarget; 2016 Apr; 7(14):18774-86. PubMed ID: 26959748
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Spinal Myxopapillary Ependymomas Demonstrate a Warburg Phenotype.
    Mack SC; Agnihotri S; Bertrand KC; Wang X; Shih DJ; Witt H; Hill N; Zayne K; Barszczyk M; Ramaswamy V; Remke M; Thompson Y; Ryzhova M; Massimi L; Grajkowska W; Lach B; Gupta N; Weiss WA; Guha A; Hawkins C; Croul S; Rutka JT; Pfister SM; Korshunov A; Pekmezci M; Tihan T; Philips JJ; Jabado N; Zadeh G; Taylor MD
    Clin Cancer Res; 2015 Aug; 21(16):3750-8. PubMed ID: 25957288
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastoma.
    Sanzey M; Abdul Rahim SA; Oudin A; Dirkse A; Kaoma T; Vallar L; Herold-Mende C; Bjerkvig R; Golebiewska A; Niclou SP
    PLoS One; 2015; 10(5):e0123544. PubMed ID: 25932951
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Combinatorial regulation of neuroblastoma tumor progression by N-Myc and hypoxia inducible factor HIF-1alpha.
    Qing G; Skuli N; Mayes PA; Pawel B; Martinez D; Maris JM; Simon MC
    Cancer Res; 2010 Dec; 70(24):10351-61. PubMed ID: 20961996
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Histology-based expression profiling yields novel prognostic markers in human glioblastoma.
    Dong S; Nutt CL; Betensky RA; Stemmer-Rachamimov AO; Denko NC; Ligon KL; Rowitch DH; Louis DN
    J Neuropathol Exp Neurol; 2005 Nov; 64(11):948-55. PubMed ID: 16254489
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.